Company Update

Welcure Drugs & Pharmaceuticals Limited has announced a board meeting on 22 August 2025, to consider a stock split of equity shares in the ratio of 1:10, and an issue of bonus shares up to 1:1. These proposed corporate actions aim to broaden investor participation and enhance liquidity by reducing the per-share acquisition cost.

A bonus issue, if approved, rewards existing shareholders.

Combined, a shareholder holding one share could potentially hold up to 20 shares post-actions, without altering their proportional ownership or the company's total market capitalization.